U.S. Markets open in 2 hrs 3 mins

AcelRx Pharmaceuticals, Inc. (ACRX)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
2.05-0.20 (-8.89%)
At close: 4:00PM EDT
People also watch
ALIMECYTAVEOAEGRINFI
Full screen
Previous Close2.25
Open2.25
Bid2.15 x 6000
Ask2.25 x 2000
Day's Range2.05 - 2.35
52 Week Range1.95 - 4.08
Volume799,430
Avg. Volume362,851
Market Cap93.03M
Beta2.91
PE Ratio (TTM)-1.95
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube15 days ago

    ETFs with exposure to AcelRx Pharmaceuticals, Inc. : June 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AcelRx Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ACRX-US. Comparing the performance and risk of AcelRx Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
    Capital Cube2 months ago

    AcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017

    Categories: Yahoo FinanceGet free summary analysis AcelRx Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of AcelRx Pharmaceuticals, Inc. – Pain Therapeutics, Inc., Insys Therapeutics, Inc., Medicines Company and Cara Therapeutics Inc (PTIE-US, INSY-US, MDCO-US and CARA-US) that have also reported for this period. ... Read more (Read more...)

  • Associated Press2 months ago

    AcelRx Pharmaceuticals reports 1Q loss

    The Redwood City, California-based company said it had a loss of 34 cents per share. The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment ...